tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
The FlyPsychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
13d ago
ATAI
CMND
PharmaTher Sets Path for Ketamine Commercialization with FDA Approval Goal
PremiumCompany Announcements
PharmaTher Sets Path for Ketamine Commercialization with FDA Approval Goal
14d ago
PharmaTher sees path to ketamine commercialization with no planned financing
PremiumThe Fly
PharmaTher sees path to ketamine commercialization with no planned financing
14d ago
PharmaTher Secures U.S. Patent for Ketamine in ALS, Strengthening Market Position
PremiumCompany Announcements
PharmaTher Secures U.S. Patent for Ketamine in ALS, Strengthening Market Position
22d ago
PharmaTher secures U.S. patent for ketamine in ALS
PremiumThe Fly
PharmaTher secures U.S. patent for ketamine in ALS
22d ago
PharmaTher Supports FDA’s New Program to Fast-Track Ketamine Therapies
PremiumCompany AnnouncementsPharmaTher Supports FDA’s New Program to Fast-Track Ketamine Therapies
28d ago
PharmaTher ‘applauds’ FDA’s new CNPV program
Premium
The Fly
PharmaTher ‘applauds’ FDA’s new CNPV program
28d ago
Psychedelic: atai Life Sciences reports Phase 2a study data on BPL-003
Premium
The Fly
Psychedelic: atai Life Sciences reports Phase 2a study data on BPL-003
2M ago
ATAI
ENVB
PharmaTher’s Ketamine Drug Review Extended by FDA
PremiumCompany Announcements
PharmaTher’s Ketamine Drug Review Extended by FDA
2M ago
PharmaTher says FDA extends review period for ketamine
PremiumThe Fly
PharmaTher says FDA extends review period for ketamine
2M ago
PharmaTher Launches KetaVault™ to Propel Ketamine Innovation
PremiumCompany Announcements
PharmaTher Launches KetaVault™ to Propel Ketamine Innovation
2M ago
PharmaTher unveils KetaVault portal
PremiumThe Fly
PharmaTher unveils KetaVault portal
2M ago
PharmaTher Receives FDA Approval Goal Date for Ketamine
PremiumCompany AnnouncementsPharmaTher Receives FDA Approval Goal Date for Ketamine
4M ago
PharmaTher receives FDA approval goal date for ketamine
Premium
The Fly
PharmaTher receives FDA approval goal date for ketamine
4M ago
PharmaTher Resubmits FDA Application for Ketamine, Aiming for Q2-2025 Approval
Premium
Company Announcements
PharmaTher Resubmits FDA Application for Ketamine, Aiming for Q2-2025 Approval
5M ago
PharmaTher Advances Towards FDA Approval for Ketamine with Resubmission Plan
PremiumCompany Announcements
PharmaTher Advances Towards FDA Approval for Ketamine with Resubmission Plan
5M ago
PharmaTher expects to submit minor amendment to CRL by end of February
PremiumThe Fly
PharmaTher expects to submit minor amendment to CRL by end of February
5M ago
PharmaTher Eyes FDA Approval and Future Growth in Ketamine Market
PremiumCompany Announcements
PharmaTher Eyes FDA Approval and Future Growth in Ketamine Market
6M ago
PharmaTher ‘on track’ to submit responses to FDA in February
PremiumThe Fly
PharmaTher ‘on track’ to submit responses to FDA in February
6M ago
PharmaTher Updates on Ketamine Drug Application
PremiumCompany AnnouncementsPharmaTher Updates on Ketamine Drug Application
8M ago
PharmaTher initiates activities to address ‘minor deficiencies’ in ketamine NDA
Premium
The Fly
PharmaTher initiates activities to address ‘minor deficiencies’ in ketamine NDA
8M ago
PharmaTher Updates on FDA Ketamine Application
Premium
Company Announcements
PharmaTher Updates on FDA Ketamine Application
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >